Group structure

Through Hutchison MediPharma, Chi-Med researches and develops botanical and small molecule drugs for the global market. We focus on the oncology and immunology therapeutic areas.

Chi-Med has three operating joint ventures in the fast growing China pharmaceutical market: Hutchison Baiyunshan; Shanghai Hutchison Pharmaceuticals; and Hutchison Healthcare. These joint ventures are increasingly strong cash generators from the development, manufacture and marketing of both prescription and over-the-counter pharmaceuticals and health supplements. Chi-Med plans to establish further joint ventures in the future.

Chi-Med is developing multiple natural and organic consumer products businesses in both China and Europe.